Avoro Capital Advisors’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-3,500,000
| Closed | -$25.9M | – | 36 |
|
2024
Q4 | $25.9M | Sell |
3,500,000
-740,000
| -17% | -$5.48M | 0.37% | 32 |
|
2024
Q3 | $39.8M | Sell |
4,240,000
-7,460,000
| -64% | -$70M | 0.58% | 28 |
|
2024
Q2 | $93.8M | Hold |
11,700,000
| – | – | 1.25% | 20 |
|
2024
Q1 | $173M | Buy |
11,700,000
+5,000,000
| +75% | +$74.1M | 2.02% | 17 |
|
2023
Q4 | $54.5M | Hold |
6,700,000
| – | – | 0.75% | 22 |
|
2023
Q3 | $30.5M | Hold |
6,700,000
| – | – | 0.48% | 25 |
|
2023
Q2 | $47.2M | Sell |
6,700,000
-320,000
| -5% | -$2.25M | 0.64% | 24 |
|
2023
Q1 | $42.9M | Hold |
7,020,000
| – | – | 0.64% | 22 |
|
2022
Q4 | $44.9M | Sell |
7,020,000
-2,000,000
| -22% | -$12.8M | 0.67% | 24 |
|
2022
Q3 | $86.4M | Sell |
9,020,000
-200,000
| -2% | -$1.92M | 1.6% | 17 |
|
2022
Q2 | $102M | Buy |
9,220,000
+95,000
| +1% | +$1.05M | 2.01% | 14 |
|
2022
Q1 | $152M | Buy |
9,125,000
+450,000
| +5% | +$7.49M | 2.77% | 14 |
|
2021
Q4 | $166M | Buy |
8,675,000
+175,000
| +2% | +$3.34M | 2.82% | 11 |
|
2021
Q3 | $210M | Sell |
8,500,000
-600,000
| -7% | -$14.8M | 3.29% | 8 |
|
2021
Q2 | $237M | Buy |
9,100,000
+1,100,000
| +14% | +$28.6M | 4.12% | 8 |
|
2021
Q1 | $253M | Buy |
8,000,000
+500,000
| +7% | +$15.8M | 4.37% | 8 |
|
2020
Q4 | $348M | Sell |
7,500,000
-2,036,039
| -21% | -$94.5M | 5.99% | 4 |
|
2020
Q3 | $314M | Sell |
9,536,039
-825,000
| -8% | -$27.2M | 4.46% | 4 |
|
2020
Q2 | $284M | Buy |
10,361,039
+1,350,626
| +15% | +$37.1M | 5.62% | 4 |
|
2020
Q1 | $270M | Buy |
9,010,413
+184,374
| +2% | +$5.52M | 9.1% | 3 |
|
2019
Q4 | $244M | Sell |
8,826,039
-1,775,000
| -17% | -$49.1M | 7.17% | 4 |
|
2019
Q3 | $193M | Sell |
10,601,039
-151,546
| -1% | -$2.76M | 8.05% | 3 |
|
2019
Q2 | $264M | Buy |
10,752,585
+221,723
| +2% | +$5.44M | 9.11% | 3 |
|
2019
Q1 | $100M | Buy |
10,530,862
+269,823
| +3% | +$2.57M | 4.33% | 10 |
|
2018
Q4 | $90.8M | Buy |
10,261,039
+1,598,319
| +18% | +$14.1M | 5.43% | 7 |
|
2018
Q3 | $97.5M | Buy |
8,662,720
+485,000
| +6% | +$5.46M | 4.48% | 8 |
|
2018
Q2 | $105M | Buy |
8,177,720
+99,215
| +1% | +$1.27M | 4.03% | 8 |
|
2018
Q1 | $137M | Buy |
8,078,505
+2,825,055
| +54% | +$47.7M | 6.52% | 4 |
|
2017
Q4 | $42M | Buy |
5,253,450
+1,052,107
| +25% | +$8.42M | 2.72% | 15 |
|
2017
Q3 | $32.6M | Buy |
4,201,343
+50,000
| +1% | +$387K | 2.53% | 16 |
|
2017
Q2 | $30.5M | Sell |
4,151,343
-400,000
| -9% | -$2.94M | 3.85% | 10 |
|
2017
Q1 | $33.9M | Buy |
4,551,343
+30,700
| +0.7% | +$229K | 4.33% | 8 |
|
2016
Q4 | $31.4M | Buy |
4,520,643
+263,296
| +6% | +$1.83M | 6.35% | 4 |
|
2016
Q3 | $35M | Sell |
4,257,347
-81,210
| -2% | -$668K | 6.15% | 3 |
|
2016
Q2 | $35.1M | Buy |
4,338,557
+1,213,359
| +39% | +$9.83M | 7.81% | 2 |
|
2016
Q1 | $15.9M | Sell |
3,125,198
-62,409
| -2% | -$317K | 5.54% | 7 |
|
2015
Q4 | $24.6M | Buy |
3,187,607
+6,694
| +0.2% | +$51.7K | 8.48% | 3 |
|
2015
Q3 | $18.3M | Buy |
3,180,913
+257,848
| +9% | +$1.49M | 4.76% | 8 |
|
2015
Q2 | $26.8M | Buy |
2,923,065
+773,158
| +36% | +$7.09M | 7.38% | 4 |
|
2015
Q1 | $26M | Buy |
+2,149,907
| New | +$26M | 9.99% | 2 |
|